How animals regulate organ size is unknown. Recent studies in Drosophila point towards a novel signaling pathway called """"""""hippo"""""""" as an important regulator of organ growth. Cells that are mutant for components of the hippo signaling pathway exhibit features of overgrowth accompanied by increased proliferation and attenuated apoptosis. In mammals, conserved orthologs of each hippo pathway component have been found. However, the role of hippo signaling in mammals has not been explored. Here we propose to define the role of hippo signaling in the mouse mammary gland. The mouse mammary gland is uniquely suited for these studies as it undergoes hormone-induced waves of proliferation and apoptosis during normal development and pregnancy. Moreover, the mammary gland is dispensable for viability, allowing application of conditional approaches for assessment of hippo function. We have generated conditional alleles at several key core hippo pathway components and are in the process of analyzing the phenotype of animals that have reduced or absent hippo signaling in the mammary gland. Preliminary data suggests that as in Drosophila, hippo signaling plays an important role in preventing overgrowth. We will extend these preliminary observations by systematically deleting core components of the hippo signaling pathway in the mouse mammary gland and by applying a series of cytological, cell-based, and molecular methods to define both the requirement for hippo signaling and to define how hippo signaling controls mammary gland growth on a molecular level. In summary, the proposed research will define functions for hippo signaling in the normal mammary gland and thus provide novel insight into mechanism of organ size control in mammalian tissues.

Public Health Relevance

This research project employs a model mammalian genetic organism, the mouse, to uncover the genetic control of organ growth and cell proliferation, a process of immediate relevance to human health and disease. Growth is critical for normal development and growth control is defective in cancer cells. Given the conservation of genes and pathways required for most fundamental biological processes in mice and humans, we expect that this project will inform our understanding of growth control and cell proliferation in man and in pathophysiological states, such as cancer.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD060579-02
Application #
7894938
Study Section
Development - 2 Study Section (DEV2)
Program Officer
Javois, Lorette Claire
Project Start
2009-08-01
Project End
2011-07-31
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
2
Fiscal Year
2010
Total Cost
$380,412
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Biochemistry
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Kim, Minchul; Kim, Taekhoon; Johnson, Randy L et al. (2015) Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Cell Rep 11:270-82
Anakk, Sayeepriyadarshini; Bhosale, Manoj; Schmidt, Valentina A et al. (2013) Bile acids activate YAP to promote liver carcinogenesis. Cell Rep 5:1060-9
Hippenmeyer, Simon; Johnson, Randy L; Luo, Liqun (2013) Mosaic analysis with double markers reveals cell-type-specific paternal growth dominance. Cell Rep 3:960-7
George, Nicholas M; Day, Caroline E; Boerner, Brian P et al. (2012) Hippo signaling regulates pancreas development through inactivation of Yap. Mol Cell Biol 32:5116-28
Heallen, Todd; Zhang, Min; Wang, Jun et al. (2011) Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332:458-61
Lu, Li; Li, Ying; Kim, Soo Mi et al. (2010) Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A 107:1437-42